Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Carotuximab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kairos Pharma Wins 2025 R&D Award for Advanced Prostate Cancer
    Kairos Pharma Wins 2025 R&D Award for Advanced Prostate Cancer

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217192511/en/Kairos-Pharma-Wins-2025-Clinical-Trials-Arena-Research-and-Development-Excellence-Award-for-Advanced-Prostate-Cancer

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Kairos Presents on Ph 2 of ENV-105 in Advanced Prostate Cancer
    Kairos Presents on Ph 2 of ENV-105 in Advanced Prostate Cancer

    20 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020246445/en/Kairos-Pharma-Presents-on-Phase-2-Trial-of-ENV-105-in-Advanced-Prostate-Cancer-at-European-Society-Medical-Oncologists-ESMO-Meeting

    BUSINESSWIRE
    20 Oct 2025
    Share Share
    Kairos Pharma Reports Positive Safety Results in ENV-105 Phase 2
    Kairos Pharma Reports Positive Safety Results in ENV-105 Phase 2

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250715146338/en/Kairos-Pharma-Announces-Positive-Safety-Results-from-Phase-2-Trial-of-ENV-105-in-Advanced-Prostate-Cancer

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.